B&G Foods (BGS) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
18 Dec, 2025Executive summary
Fourth quarter and full year 2024 results showed sequential improvement and met or exceeded expectations, despite ongoing softness in consumer demand and the impact of the Green Giant U.S. shelf-stable divestiture.
Fiscal 2024 was challenging, with base business net sales down 3.3% year-over-year, but the Spices & Flavor Solutions unit delivered strong growth.
The company transitioned from a single segment to four business segments: Specialty, Meals, Frozen & Vegetables, and Spices & Flavor Solutions.
Portfolio reshaping is a priority, with a focus on core shelf-stable businesses and consideration of divesting frozen and canned vegetable units.
Financial highlights
Fiscal 2024 net sales were $1.932 billion, with a net loss of $251.3 million, mainly due to $390.6 million in non-cash impairment charges.
Fourth quarter net sales were $551.6 million, with adjusted EBITDA of $86.1 million; full year adjusted EBITDA was $295.4 million (15.3% of net sales).
Adjusted net income for 2024 was $55.7 million, or $0.70 per adjusted diluted share; adjusted EBITDA for Q4 2024 was $86.1 million.
Fourth quarter adjusted gross profit margin improved to 22.2% from 21.9% year-over-year.
Net debt reduced to $1.994 billion at year-end, with no near-term maturities after redeeming $265 million in senior notes.
Outlook and guidance
Fiscal 2025 net sales projected at $1.89–$1.95 billion, with adjusted EBITDA of $290–$300 million and adjusted EPS of $0.65–$0.75.
Guidance assumes flat to slightly down net sales in the first half, improving in the second half, and a $10–$15 million benefit from a 53rd week.
Management expects soft trends in the first half of 2025, with sequential improvement in the second half as the company laps high inflation impacts.
Interest expense expected at $147.5–$152.5 million, CapEx at $35–$40 million, and effective tax rate at 26%–27%.
Latest events from B&G Foods
- Portfolio transformation and divestitures drive margin gains and lower leverage for 2026.BGS
Q4 20253 Mar 2026 - Q2 sales fell 5.3%, goodwill impairment hit results, and guidance was revised lower.BGS
Q2 20242 Feb 2026 - Portfolio reshaping and operational improvements target margin recovery and 2024 growth.BGS
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026 - Q3 2024 sales and EBITDA declined, but net income turned positive; outlook remains cautious.BGS
Q3 202416 Jan 2026 - Portfolio streamlining and cost initiatives aim to boost margins and enable future growth.BGS
Barclays 18th Annual Global Consumer Staples Conference 202531 Dec 2025 - Shelf registration allows up to $800M in securities for growth, debt, and acquisitions.BGS
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG and governance.BGS
Proxy Filing1 Dec 2025 - Director elections, executive pay, and auditor ratification up for virtual shareholder vote.BGS
Proxy Filing1 Dec 2025 - Q1 2025 sales dropped 10.5% and EBITDA fell 21.2%, prompting lower guidance and cost cuts.BGS
Q1 202525 Nov 2025